A detailed history of Flaharty Asset Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Flaharty Asset Management, LLC holds 300 shares of ARGX stock, worth $169,269. This represents 0.02% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$169,269
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$434.22 - $551.9 $130,266 - $165,570
300 New
300 $162,000
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $110,805 - $164,528
300 New
300 $147,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Flaharty Asset Management, LLC Portfolio

Follow Flaharty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flaharty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flaharty Asset Management, LLC with notifications on news.